Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
Clinical trial NCT00306033 · COMPLETED
Trial details
- NCT number
- NCT00306033
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.